<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Pharmacology / Pharmaceuticals policy / Pharmacy / Good Clinical Practice / Clinical Trials Directive / Pharmacovigilance / Clinical trial / Medicines and Healthcare products Regulatory Agency / Clinical research / Pharmaceutical sciences / Research
Date: 2008-05-24 08:37:27
Pharmaceutical industry
Pharmacology
Pharmaceuticals policy
Pharmacy
Good Clinical Practice
Clinical Trials Directive
Pharmacovigilance
Clinical trial
Medicines and Healthcare products Regulatory Agency
Clinical research
Pharmaceutical sciences
Research

Mail The MCA updating service No. 134 November/December[removed]l

Add to Reading List

Source URL: www.mhra.gov.uk

Download Document from Source Website

File Size: 585,42 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document